Emergent BioSolutions Inc. Common Stock (EBS)

Emergent (EBS) Q1 2026 Earnings Transcript

Emergent (EBS) Q4 2025 Earnings Transcript

The board authorized a new $50 million share repurchase program running through March 2027.

New York State Attorney General Letitia James inked a settlement with Emergent under which the company will pay $900,000 in penalties.

Emergent BioSolutions (EBS) Earnings Transcript

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Shares of Emergent BioSolutions jumped 18% in after-hours trading after the company posted stronger-than-expected Q3 results and raised its full-year guidance.

The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.

GULFPORT, Miss. – October 23, 2025 – Hancock Whitney Corporation (NASDAQ: HWC) has once again affirmed its steadfast commitment to shareholder returns by declaring a regular fourth-quarter 2025 common stock cash dividend of $0.45 per share. Announced on October 23, 2025, this latest payout extends a remarkable tradition of uninterrupted quarterly

Discover three low P/E small-cap stocks with bullish analyst sentiment and growth potential in a lower interest rate environment

The order encompasses multiple product offerings within Emergent’s medical countermeasures business, including countermeasures for threats posed by Smallpox, Anthrax, and Botulism.

Despite share price pops after earnings, SKYT, EBS, and BLZE may still have room to rally further, as each firm has garnered strong analyst support.